26.89
+1.49(+5.87%)
Currency In USD
| Previous Close | 25.4 |
| Open | 26.72 |
| Day High | 28.63 |
| Day Low | 26.01 |
| 52-Week High | 40.37 |
| 52-Week Low | 4.3 |
| Volume | 7.01M |
| Average Volume | 2.67M |
| Market Cap | 1.23B |
| PE | -15.37 |
| EPS | -1.75 |
| Moving Average 50 Days | 7.63 |
| Moving Average 200 Days | 9.21 |
| Change | 1.49 |
If you invested $1000 in Capricor Therapeutics, Inc. (CAPR) 10 years ago, it would be worth $724.8 as of December 07, 2025 at a share price of $26.89. Whereas If you bought $1000 worth of Capricor Therapeutics, Inc. (CAPR) shares 5 years ago, it would be worth $6,111.36 as of December 07, 2025 at a share price of $26.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
GlobeNewswire Inc.
Dec 05, 2025 11:15 AM GMT
SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced the pricing of its underwritten public offering of 6,000
Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
GlobeNewswire Inc.
Dec 03, 2025 12:20 PM GMT
Pivotal Phase 3 randomized, double-blind, placebo-controlled study (n=106) met the primary endpoint (PUL v2.0) and the key secondary cardiac endpoint (LVEF), both achieving statistical significance (p=0.03 and p=0.04, respectively)Statistical signifi
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025
GlobeNewswire Inc.
Nov 24, 2025 2:00 PM GMT
--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc., (NASD